Subacute and chronic prurigo effectively treated with recombination interferon-gamma: implications for participation of Th2 cells in the pathogenesis of prurigo.

Authors

  • Y Tokura
  • H Yagi
  • K Hanaoka
  • T Ito
  • K Towyama
  • Y Sachi
  • M Tanaka
  • T Sakamoto
  • T Sekizuka
  • F Furukawa
  • M. Takigawa

DOI:

https://doi.org/10.2340/0001555577231234

Abstract

Subacute and chronic prurigo is notoriously resistant to usual therapies. Four of five patients with a subacute or chronic form of prurigo responded well to daily intravenous injections of recombinant interferon-gamma (rIFN-gamma) (0.25-2 x 10(6) Japan Reference Unit (JRU

Downloads

Download data is not yet available.

Downloads

Published

1997-05-01

How to Cite

Tokura, Y., Yagi, H., Hanaoka, K., Ito, T., Towyama, K., Sachi, Y., … Takigawa, M. (1997). Subacute and chronic prurigo effectively treated with recombination interferon-gamma: implications for participation of Th2 cells in the pathogenesis of prurigo. Acta Dermato-Venereologica, 77(3), 231–234. https://doi.org/10.2340/0001555577231234

Issue

Section

Articles